Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
21 Sep - 12 Oct 2011
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2011
Report date:
2011

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Deviations:
no
Qualifier:
according to guideline
Guideline:
JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
Version / remarks:
Kanpoan No. 287 - EPA; Eisei No. 127 - Ministry of Health & Welfare; Heisei 09/10/31 Kikyoku No.2 - Ministry of Intern. Trade & Industry
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Hess. Ministerium für Umwelt, Landwirtschaft und Forsten, Mainzer Straße 80, D-65189 Wiesbaden, Germany
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[3-(triethoxysilyl)propyl]formamide
EC Number:
700-340-6
Cas Number:
76524-94-2
Molecular formula:
C10H23NO4Si
IUPAC Name:
N-[3-(triethoxysilyl)propyl]formamide
Details on test material:
- Name of test material (as cited in study report): Y-15864
- Analytical purity: 97.5 - 99.5%
- Lot/batch No.: TER00010-68-31
- Expiration date of the lot/batch: December 09, 2012
- Storage condition of test material: at room temperature

Method

Target gene:
Salmonella typhimurium: his operon
Escherichia coli: trp operon
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Additional strain / cell type characteristics:
other: rfa-; uvrB- (R+ for TA 98 and TA 100)
Species / strain / cell type:
E. coli WP2 uvr A
Additional strain / cell type characteristics:
other: uvrA-
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix) prepared from the livers of rats treated with phenobarbital/β-naphthoflavone.
Test concentrations with justification for top dose:
Pre-Experiment and first experiment: 3, 10, 33, 100, 333, 1000, 2500 and 5000 µg/plate with and without S9 mix
Second Experiment: 33, 100, 333, 1000, 2500 and 5000 µg/plate with and without S9 mix
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The solvent was chosen because of its solubility properties and its relative non-toxicity to the bacteria.
Controls
Untreated negative controls:
yes
Remarks:
culture media
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 10 µg/plate sodium azide (TA100 and 1535, -S9), 10 µg/plate 4-nitro-o-phenylen-diamine (TA98 and 1537, -S9), 3 µL/plate methyl methane sulfonate (WP2, -S9), 2.5 µg/plate 2-aminoanthracene (2-AA) (TA98, 100, 1535, 1537, +S9), 10 µg/plate 2-AA (WP2, +S9)
Details on test system and experimental conditions:
METHOD OF APPLICATION: Experiment I: plate incorporation; Experiment II: preincubation

EXPERIMENTAL PERFORMANCE
The following materials were mixed in a test tube and poured onto the minimal agar plates:
100 µL Test solution at each dose level, solvent (negative control) or reference mutagen
solution (positive control),
500 µL S9 mix (for test with metabolic activation) or S9 mix substitution buffer (for test
without metabolic activation),
100 µL Bacteria suspension (cf. test system, pre-culture of the strains),
2000 µL Overlay agar

DURATION
- Preincubation period: 60 min
- Selection time (if incubation with a selection agent): 48 hours

SELECTION AGENT (mutation assays): minimal agar

NUMBER OF REPLICATIONS: triplicates in each of two independent experiments

DETERMINATION OF CYTOTOXICITY
- Method: relative total growth / regular background growth / spontaneous reversion rates in the negative and solvent control
Evaluation criteria:
A test item is considered as a mutagen if a biologically relevant increase in the number of revertants exceeding the threshold of twice (strains TA 98, TA 100, and WP2 uvrA) or thrice (strains TA 1535 and TA 1537) the colony count of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is exceeded at more than one concentration.
An increase exceeding the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant.
Statistics:
Mean and standard deviation were calculated.

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
COMPARISON WITH HISTORICAL CONTROL DATA: Yes
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table 1: Summary Ames Test Results – Pre-Experiment and Experiment 1

With or without S9-Mix

Test substance concentration

(μg/plate)

Mean number of revertant colonies per plate

(average of triplicate)

Base-pair substitution type

Frameshift type

Base-pair substitution and other

TA 1535

TA100

TA1537

TA98

WP2 uvrA

-

Negative control

18±5

144±13

12±3

41±2

45±6

-

Vehicle control

15±4

139±3

11±3

32±3

43±4

-

3

16±4

138±12

13±5

30±5

42±7

-

10

15±5

127±7

12±2

32±8

43±4

-

33

13±3

134±10

14±4

31±8

36±6

-

100

17±5

141±10

11±4

35±5

41±7

-

333

13±3

147±5

14±4

36±5

43±11

-

1000

10±2

145±8

11±1

35±5

41±1

-

2500

11±5

147±7

12±4

31±10

38±3

-

5000

11±1

122±10

9±2

38±4

33±4

Positive

controls

- S9

Name

NaN3

NaN3

4-NOPD

4-NOPD

MMS

Concentrations

(μg/plate)

10

10

50

10

3.0 µL

Number of colonies/plate

1726±40

1998±64

84±7

385±32

1043±98

 

TA 1535

TA 100

TA1537

TA98

WP2 uvrA

+

Negative control

17±5

127±11

16±4

41±2

62±13

+

Vehicle control

21±5

133±10

17±4

41±11

52±3

+

3

19±2

119±9

16±1

45±2

50±6

+

10

23±3

124±5

16±3

41±6

48±7

+

33

21±3

129±17

16±4

40±5

47±3

+

100

16±1

129±20

16±3

35±6

48±2

+

333

19±3

128±8

19±6

44±3

48±8

+

1000

16±1

119±9

18±3

38±3

51±6

+

2500

18±3

143±28

15±5

42±7

44±7

+

5000

20±4

142±20

13±3

39±5

50±8

Positive

controls

+ S9

Name

2-AA

2-AA

2-AA

2-AA

2-AA

Concentrations

(μg/plate)

2.5

2.5

2.5

2.5

10.0

Number of colonies/plate

329±14

1316±2

184±14

1458±56

198±19

Table 2: Summary Ames Test Results - Experiment 2

With or without S9-Mix

Test substance concentration

(μg/plate)

Mean number of revertant colonies per plate

(average of triplicate)

Base-pair substitution type

Frameshift type

Base-pair substitution and other

TA 1535

TA100

TA1537

TA98

WP2 uvrA

-

Negative control

9±3

124±11

19±6

35±8

41±7

-

Vehicle control

9±1

102±8

11±2

27±10

48±3

-

33

11±3

109±6

11±1

28±8

43±1

-

100

12±2

101±12

11±5

23±3

49±5

-

333

9±2

98±4

12±2

26±3

42±6

-

1000

11±3

91±11

11±3

31±4

45±4

-

2500

11±2

91±8

13±3

27±8

48±6

-

5000

10±1

66±6

11±3

22±6

41±3

Positive

controls

- S9

Name

NaN3

NaN3

4-NOPD

4-NOPD

MMS

Concentrations

(μg/plate)

10

10

50

10

3.0 µL

Number of colonies/plate

1633±7

1672±50

78±12

339±21

443±64

 

TA 1535

TA 100

TA1537

TA98

WP2 uvrA

+

Negative control

16±5

144±15

22±6

38±4

62±8

+

Vehicle control

16±4

110±9

15±6

39±4

48±9

+

33

15±5

114±13

18±3

43±2

51±5

+

100

19±4

123±12

18±3

41±1

51±11

+

333

16±2

114±8

16±3

38±8

49±3

+

1000

15±4

107±6

13±3

41±3

49±9

+

2500

17±6

126±4

16±2

35±4

47±4

+

5000

19±6

117±11

17±5

43±2

51±9

Positive

controls

+ S9

Name

2-AA

2-AA

2-AA

2-AA

2-AA

Concentrations

(μg/plate)

2.5

2.5

2.5

2.5

10.0

Number of colonies/plate

260±9

1510±152

185±0

1382±7

312±9

NaN3 = sodium azide

2-AA = 2-aminoanthracene

4-NOPD = 4 -nitro-o-phenylene-diamine

MMS = methyl methane sulfonate

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative
Executive summary:

N-[3-(Triethoxysilyl)propyl]formamide was tested in an Ames test using Salmonella typhimurium strains TA 1535, TA 1537, TA 98, and TA 100 and the Escherichia coli strain WP2 uvrA. The substance was tested up to 5000 µg/plate with and without metabolic activation. No toxic effects occurred in the test groups with and without S9 mix. Under the experimental conditions the test item did not induce mutations by base pair changes or frameshifts in the genome of the strains used.